Internship

Intern – Commercial MBA Leadership Development Program Internship

Summer 2025

Confirmed live in the last 24 hours

Bristol-Myers Squibb

Bristol-Myers Squibb

10,001+ employees

Develops and delivers biopharmaceutical medicines

Biotechnology
Healthcare

No H1B Sponsorship

Princeton, NJ, USA

Hybrid position requiring in-office presence.

Category
Strategy Development
Business Development
Business & Strategy
Required Skills
Sales
Marketing
Data Analysis
Requirements
  • Enrolled in a Master of Business Administration (MBA) degree program during the current school year (graduating class of 2026)
  • All candidates must be authorized to work in the US at the time of hire. Please note that immigration or visa sponsorship is not available for this position.
  • Minimum 3 years of work experience
  • Experience in marketing, sales and/or healthcare/pharmaceutical industry preferred, but not mandatory
  • Demonstrated leadership in student, community, or professional organizations
  • The ability to gather, analyze and translate data to gain a deeper understanding of the customer, brand, disease area, market, and competition
  • Ability to lead without authority and possess strong project management capabilities
  • Diverse thinking with innovative ideas and new approaches to maximize opportunities
Responsibilities
  • Develop and launch new sales force promotional materials
  • Collaborate with global markets to inform strategy for future clinical trials and launches
  • Translate data insights to create new patient education resources
  • An introduction to brand planning and marketing excellence in the biopharma industry
  • Lunch-and-Learns on key biopharma business topics including senior leader speaker series/panels on different commercial career paths at BMS
  • Formal mentorship with commercial leaders and current full-time CLDP associates
  • Teambuilding and networking events
  • Final presentation to senior leaders & team members on summer projects

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, particularly in oncology, immunology, and cardiovascular health. The company conducts extensive research and development to create new drugs, which are then sold after receiving regulatory approval. BMS also produces generic drugs that are affordable alternatives to their innovative medicines, ensuring they meet the same quality and safety standards. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, as well as its commitment to sustainability and corporate responsibility. The company's goal is to improve patient outcomes by providing access to effective and affordable healthcare solutions.

Company Stage

IPO

Total Funding

$33.7B

Headquarters

New York City, New York

Founded

1887

Simplify Jobs

Simplify's Take

What believers are saying

  • BMS's involvement in Nobel Prize-winning immunology research underscores its leadership in groundbreaking scientific advancements.
  • The robust pipeline of molecular glues and other innovative therapies promises significant revenue growth and market expansion.
  • Recognition in the Dow Jones Sustainability Index North America highlights BMS's commitment to corporate responsibility and sustainability, enhancing its reputation and stakeholder trust.

What critics are saying

  • The termination of strategic collaborations, such as with Eisai, could impact BMS's ability to bring new therapies to market efficiently.
  • Ongoing layoffs and restructuring efforts may lead to decreased employee morale and potential disruptions in operations.

What makes Bristol-Myers Squibb unique

  • Bristol Myers Squibb's dual focus on innovative and generic medicines allows it to cater to a broad spectrum of healthcare needs, unlike competitors who may focus solely on one area.
  • Their commitment to sustainability and ESG goals sets them apart in the biopharmaceutical industry, appealing to socially conscious investors and stakeholders.
  • BMS's extensive R&D investment in oncology, immunology, and cardiovascular diseases positions it as a leader in developing cutting-edge treatments for serious diseases.

Help us improve and share your feedback! Did you find this helpful?